How it works.
Cagrilintide is a 37-residue acylated amylin analog engineered for extended pharmacokinetics. It engages amylin and calcitonin receptors, producing effects on satiety, gastric emptying, and glucagon secretion that are mechanistically distinct from incretin pathways. In recent metabolic research it is most often studied alongside GLP-1 agonists, where the dual mechanism produces additive effects on body composition and glycemic markers in animal models.
Verified buyer notes.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Shipment got delayed two days by weather and still arrived at 4°C. Packaging is no joke.”
The shared signature.
04Coming soonA dual GIP/GLP-1 receptor agonist studied for its effects on glycemic regulation and adipose tissue metabolism.
04Coming soonA long-acting GLP-1 receptor agonist studied for its effects on glycemic control, satiety signaling, and adipose tissue.
04Coming soonA 16-amino-acid fragment of human growth hormone studied for its effects on lipolysis without GH receptor activity.